Hypertrophic cardiomyopathy in a patient with secondary hypoparathyroidism: A case report

Juan Felipe Betancur1, Christian Adams-Sánchez2, Lina Restrepo-Giraldo3

  • 1Leader Internal Medicine Research Group, Ayudas Diagnosticas SURA Biociencias I+D, Internal Medicine Department, Clínica Medellín - Grupo Quirónsalud, CES University, Medellín, Colombia.

Radiology Case Reports
|October 4, 2022
PubMed

Insights

Chronic hypoparathyroidism can affect the heart, typically causing dilated cardiomyopathy. This case study presents a rare instance of hypertrophic cardiomyopathy in a patient with chronic hypoparathyroidism and hypocalcemia.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Parathyroid hormone (PTH) influences cardiovascular cells, but the cardiac effects of chronic hypoparathyroidism remain incompletely understood.
  • Low PTH states are linked to various acute and chronic cardiac manifestations.
  • Hypocalcemic cardiomyopathy can present acutely as transient dilated cardiomyopathy or chronically, potentially leading to heart failure.

Observation:

  • This study details a 73-year-old woman with chronic hypoparathyroidism and hypocalcemia.
  • The patient developed hypertrophic cardiomyopathy.
  • This presentation is atypical, as chronic hypoparathyroidism-associated cardiomyopathy usually manifests as dilated cardiomyopathy.

Findings:

  • Chronic hypoparathyroidism can lead to diverse cardiac pathologies beyond the typical dilated form.
  • Hypertrophic cardiomyopathy is an unusual manifestation of chronic hypoparathyroidism and hypocalcemia.
  • This case highlights the varied cardiac remodeling possible in low PTH states.

Implications:

  • Clinicians should consider hypertrophic cardiomyopathy in patients with chronic hypoparathyroidism presenting with cardiac abnormalities.
  • Further research is needed to elucidate the mechanisms underlying different forms of hypoparathyroidism-associated cardiomyopathy.
  • Understanding these associations can improve diagnosis and management of cardiac complications in hypoparathyroid patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
2.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
28
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
40